United Therapeutics (UTHR) Return on Assets [ROA] (2010 - 2026)
United Therapeutics (UTHR) posted Return on Assets [ROA] of 18.82% for Q2 2026, up 2.94 percentage points from 15.87% a year earlier and up 1.17 percentage points from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) Return on Assets [ROA] (2010 - 2026) Analysis & Trends
For FY2025, United Therapeutics' Return on Assets [ROA] came in at 17.51%, up 1.06 percentage points from FY2024.
- Annual Return on Assets [ROA] has increased for four consecutive years, with a five-year change of +5.44 percentage points (FY2020 to FY2025).
- In prior years, United Therapeutics' Return on Assets [ROA] was 16.45% in FY2024 (+1.54 pp), 14.91% in FY2023 (+1.94 pp), 12.97% in FY2022 (+3.25 pp) and 9.73% in FY2021 (-2.35 pp).
- The Q2 2026 figure stands as the highest quarterly Return on Assets [ROA] since Q2 2018.
- On a year-over-year basis, Return on Assets [ROA] has increased in each of the last four quarters, with an average year-over-year change of +1.51 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Assets [ROA] in the past five years was Q1 2022, with a gain of 4.30 percentage points; the weakest was Q4 2021, with a drop of 2.09 percentage points.
- According to Business Quant data, Return on Assets [ROA] for the three prior quarters was 17.64% (Q1 2026), 17.53% (Q4 2025) and 16.67% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | United Therapeutics | 23.13 Bn | 12.62 Bn | 683.80 Mn | 18.82% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 18.82% |
| Mar 31, 2026 | 17.64% |
| Dec 31, 2025 | 17.53% |
| Sep 30, 2025 | 16.67% |
| Jun 30, 2025 | 15.87% |
| Mar 31, 2025 | 16.03% |
| Dec 31, 2024 | 16.50% |
| Sep 30, 2024 | 16.05% |
| Jun 30, 2024 | 16.18% |
| Mar 31, 2024 | 15.38% |
| Dec 31, 2023 | 13.88% |
| Sep 30, 2023 | 13.13% |
| Jun 30, 2023 | 13.38% |
| Mar 31, 2023 | 11.76% |
| Dec 31, 2022 | 12.30% |
| Sep 30, 2022 | 12.49% |
| Jun 30, 2022 | 11.57% |
| Mar 31, 2022 | 13.06% |
| Dec 31, 2021 | 9.31% |
| Sep 30, 2021 | 9.35% |
API Access
United Therapeutics Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();